Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities – Role of gut microbiota dysbiosis
Sofia Viana, Sara Nunes, Flávio Reis
Ageing Research Reviews (2020) Vol. 62, pp. 101123-101123
Open Access | Times Cited: 170

Showing 26-50 of 170 citing articles:

COVID-19: Gastrointestinal manifestations, liver injury and recommendations
Zülal Özkurt, Esra Çınar Tanrıverdi
World Journal of Clinical Cases (2022) Vol. 10, Iss. 4, pp. 1140-1163
Open Access | Times Cited: 31
Impairment of neutrophil functions and homeostasis in COVID-19 patients: association with disease severity
Chloé Loyer, Arnaud Lapostolle, Tomas Urbina, et al.
Critical Care (2022) Vol. 26, Iss. 1
Open Access | Times Cited: 31
Role of the Microbiome in the Pathogenesis of COVID-19
Rituparna De, Shanta Dutta
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 30
Correlation of gut microbiota and metabolic functions with the antibody response to the BBIBP-CorV vaccine
Bo Tang, Li Tang, Wei He, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 10, pp. 100752-100752
Open Access | Times Cited: 30
Gut Microbiota Dysbiosis in COVID-19: Modulation and Approaches for Prevention and Therapy
Virna Margarita Martín Giménez, Javier Modrego, Dulcenombre Gómez‐Garré, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12249-12249
Open Access | Times Cited: 18
Gut microbiota in COVID-19: new insights from inside
Bingqian Zhou, Xiaoqi Pang, Jingyi Wu, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 16
Serotonergic psychedelics as potential therapeutics for post-COVID-19 syndrome (or Long COVID): A comprehensive review
Zhen Xuen Brandon Low, Shin Jie Yong, Hayam A Alrasheed, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111279-111279
Closed Access
The role of gut–islet axis in pancreatic islet function and glucose homeostasis
Qi Chen, Yuanyuan Gao, Fangyu Li, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Is Gut Microbiota Dysbiosis a Predictor of Increased Susceptibility to Poor Outcome of COVID-19 Patients? An Update
Carolina Ferreira, Sofia Viana, Flávio Reis
Microorganisms (2020) Vol. 9, Iss. 1, pp. 53-53
Open Access | Times Cited: 46
Intestinal Barrier Function in Health and Disease—Any Role of SARS-CoV-2?
Lakshya Sharma, Antonio Riva
Microorganisms (2020) Vol. 8, Iss. 11, pp. 1744-1744
Open Access | Times Cited: 41
Impact of Dietary Sugars on Gut Microbiota and Metabolic Health
Karina Garcia, Gonçalo Ferreira, Flávio Reis, et al.
Diabetology (2022) Vol. 3, Iss. 4, pp. 549-560
Open Access | Times Cited: 26
Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity
Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 25, pp. 2802-2822
Open Access | Times Cited: 24
Gut Microbiota and COVID-19: Potential Implications for Disease Severity
Giulia Rocchi, Marta Giovanetti, Francesca Benedetti, et al.
Pathogens (2022) Vol. 11, Iss. 9, pp. 1050-1050
Open Access | Times Cited: 22
ACE2 contributes to the maintenance of mouse epithelial barrier function
Wei Yu, Xianhong Ou, Xiaofan Liu, et al.
Biochemical and Biophysical Research Communications (2020) Vol. 533, Iss. 4, pp. 1276-1282
Open Access | Times Cited: 35
Immunogenetic Association Underlying Severe COVID-19
Kendall McCoy, Autumn Peterson, Yun Tian, et al.
Vaccines (2020) Vol. 8, Iss. 4, pp. 700-700
Open Access | Times Cited: 34
Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis
Adonis Sfera, Carolina Osorio, Carlos Manuel Zapata Martín del Campo, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 27
Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework
Laure‐Alix Clerbaux, Maria Cristina Albertini, Núria Amigó, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 15, pp. 4464-4464
Open Access | Times Cited: 21
Modulated Gut Microbiota for Potential COVID-19 Prevention and Treatment
Shuai Zhao, Pengya Feng, Wenbo Meng, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 20
Association of Gut Microbiota with Inflammatory Bowel Disease and COVID-19 Severity: A Possible Outcome of the Altered Immune Response
Anju Kaushal, Rashed Noor
Current Microbiology (2022) Vol. 79, Iss. 6
Open Access | Times Cited: 20
The contribution of gut-brain axis to development of neurological symptoms in COVID-19 recovered patients: A hypothesis and review of literature
Kimia Vakili, Mobina Fathi, Shirin Yaghoobpoor, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 19
Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential
Hui Xiang, Qiping Liu
World Journal of Gastroenterology (2022) Vol. 28, Iss. 47, pp. 6689-6701
Open Access | Times Cited: 18
Association of gut microbiota with COVID‐19 susceptibility and severity: A two‐sample Mendelian randomization study
Weifeng Shang, Sheng Zhang, Hang Qian, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Closed Access | Times Cited: 10
Recent advance of ACE2 and microbiota dysfunction in COVID-19 pathogenesis
Zhidan Yu, Zhaojie Yang, Yuesheng Wang, et al.
Heliyon (2021) Vol. 7, Iss. 7, pp. e07548-e07548
Open Access | Times Cited: 24
Common Inflammatory Mechanisms in COVID-19 and Parkinson’s Diseases: The Role of Microbiome, Pharmabiotics and Postbiotics in Their Prevention
В. Н. Даниленко, A. V. Devyatkin, М. В. Марсова, et al.
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 6349-6381
Open Access | Times Cited: 23
Oral Bacteriotherapy Reduces the Occurrence of Chronic Fatigue in COVID-19 Patients
Letizia Santinelli, Luca Laghi, Giuseppe Pietro Innocenti, et al.
Frontiers in Nutrition (2022) Vol. 8
Open Access | Times Cited: 16

Scroll to top